Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3212707
Max Phase: Preclinical
Molecular Formula: C35H30F5N7O6
Molecular Weight: 625.64
Molecule Type: Small molecule
Associated Items:
ID: ALA3212707
Max Phase: Preclinical
Molecular Formula: C35H30F5N7O6
Molecular Weight: 625.64
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)C/C=C/C(=O)Nc1cccc(-c2c[nH]c3ncnc(Oc4ccc(NC(=O)CC(=O)Nc5ccc(F)cc5)cc4F)c23)c1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C33H29F2N7O4.C2HF3O2/c1-42(2)14-4-7-28(43)40-23-6-3-5-20(15-23)25-18-36-32-31(25)33(38-19-37-32)46-27-13-12-24(16-26(27)35)41-30(45)17-29(44)39-22-10-8-21(34)9-11-22;3-2(4,5)1(6)7/h3-13,15-16,18-19H,14,17H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,36,37,38);(H,6,7)/b7-4+;
Standard InChI Key: XRVMCRGDUJLIGK-KQGICBIGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 625.64 | Molecular Weight (Monoisotopic): 625.2249 | AlogP: 5.72 | #Rotatable Bonds: 11 |
Polar Surface Area: 141.34 | Molecular Species: BASE | HBA: 7 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.44 | CX Basic pKa: 8.78 | CX LogP: 4.92 | CX LogD: 3.50 |
Aromatic Rings: 5 | Heavy Atoms: 46 | QED Weighted: 0.11 | Np Likeness Score: -1.16 |
1. PubChem BioAssay data set, |
Source(1):